The bioinformatics platform market size has grown strongly in recent years. It will grow from $10.44 billion in 2025 to $11.27 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to growth of genomic sequencing projects, expansion of life science research, early bioinformatics tool development, academic research collaboration, increasing biological data complexity.
The bioinformatics platform market size is expected to see strong growth in the next few years. It will grow to $15.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine adoption, AI integration in bioinformatics, pharmaceutical R&D expansion, cloud computing adoption in research, demand for faster drug discovery. Major trends in the forecast period include cloud based bioinformatics platforms, AI driven genomic analysis, integrated multi omics data platforms, collaborative research data ecosystems, automated bioinformatics workflows.
The growing adoption of personalized medicine is expected to drive the growth of the bioinformatics platform market in the coming years. Personalized medicine tailors treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. This approach is gaining momentum due to advances in genomic technologies, which allow for the precise identification of genetic variations associated with diseases, enabling more targeted and effective treatments. The increasing demand for personalized medicine is fueling the need for advanced bioinformatics platforms, as these platforms are crucial for analyzing and interpreting large volumes of genomic and clinical data to develop customized treatment plans. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. As a result, the rising adoption of personalized medicine is expected to boost the growth of the bioinformatics platform market.
Leading companies in the bioinformatics platform market are developing advanced solutions, such as multiomic data mapping platforms, to provide more accurate insights and a deeper understanding of complex diseases and conditions. These platforms integrate and analyze data from multiple biological layers, including genomics, transcriptomics, proteomics, and metabolomics, to offer a comprehensive view of complex biological processes. For example, in February 2023, BioSkryb Genomics, a US-based biotechnology company, launched the BaseJumper Bioinformatics Platform. This platform enhances the ResolveOME system by simplifying large-scale single-cell informatics. It enables efficient organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, streamlining data interpretation. The platform also provides dynamic filtering and a set of visualization tools, enabling researchers across various fields to easily analyze and visualize complex datasets.
In April 2023, Excelra, an India-based informatics company, acquired BISC Global for an undisclosed amount. This acquisition creates a global leader in consulting-driven bioinformatics by combining expertise in artificial intelligence, machine learning, and omics, as well as next-generation sequencing data analysis. The merger aims to accelerate bioinformatics innovation and deliver enhanced benefits to customers from both organizations. BISC Global is a Germany-based provider of bioinformatics platforms.
Major companies operating in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Partek Incorporated, Qiagen N.V.,Genedata AG,DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., Golden Helix Inc., Benchling Inc., Velsera Inc., Seqera Labs, Lifebit Biotech Ltd., Genestack Ltd., Biomatters Ltd., Schrödinger Inc., Chemical Computing Group Inc.
North America was the largest region in the bioinformatics platform market in 2025. The regions covered in the bioinformatics platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioinformatics platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the bioinformatics platform market indirectly through higher costs of high performance computing systems and storage infrastructure. Research institutions and biotech firms in regions dependent on imported hardware have experienced increased operational costs. These impacts are more visible in large scale genomic research initiatives. Tariff related budget constraints have influenced infrastructure scaling decisions. At the same time, tariffs have accelerated adoption of cloud based bioinformatics platforms that minimize upfront hardware investments.
The bioinformatics platform market research report is one of a series of new reports that provides bioinformatics platform market statistics, including bioinformatics platform industry global market size, regional shares, competitors with a bioinformatics platform market share, detailed bioinformatics platform market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics platform industry. This bioinformatics platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A bioinformatics platform is a comprehensive software system that combines various tools, algorithms, and databases to support the analysis, interpretation, and management of biological data. These platforms often enable collaborative research by integrating multidisciplinary knowledge and resources to advance progress in healthcare, drug development, and personalized medicine.
Key bioinformatics platforms include sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and more. A sequence analysis platform is a software or toolset designed to process, analyze, and interpret biological sequences, such as DNA, RNA, or protein data. It is used in genomics, proteomics, drug discovery, personalized medicine, and other fields by a range of end-users, including pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, and others.
The bioinformatics platform market consists of revenues earned by entities by providing services such as transcriptomics services, data integration and visualization, custom pipeline development, and training and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics platform market also includes sales of biological databases, cloud computing platforms, genome annotation tools, and clinical interpretation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The bioinformatics platform market size is expected to see strong growth in the next few years. It will grow to $15.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine adoption, AI integration in bioinformatics, pharmaceutical R&D expansion, cloud computing adoption in research, demand for faster drug discovery. Major trends in the forecast period include cloud based bioinformatics platforms, AI driven genomic analysis, integrated multi omics data platforms, collaborative research data ecosystems, automated bioinformatics workflows.
The growing adoption of personalized medicine is expected to drive the growth of the bioinformatics platform market in the coming years. Personalized medicine tailors treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. This approach is gaining momentum due to advances in genomic technologies, which allow for the precise identification of genetic variations associated with diseases, enabling more targeted and effective treatments. The increasing demand for personalized medicine is fueling the need for advanced bioinformatics platforms, as these platforms are crucial for analyzing and interpreting large volumes of genomic and clinical data to develop customized treatment plans. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. As a result, the rising adoption of personalized medicine is expected to boost the growth of the bioinformatics platform market.
Leading companies in the bioinformatics platform market are developing advanced solutions, such as multiomic data mapping platforms, to provide more accurate insights and a deeper understanding of complex diseases and conditions. These platforms integrate and analyze data from multiple biological layers, including genomics, transcriptomics, proteomics, and metabolomics, to offer a comprehensive view of complex biological processes. For example, in February 2023, BioSkryb Genomics, a US-based biotechnology company, launched the BaseJumper Bioinformatics Platform. This platform enhances the ResolveOME system by simplifying large-scale single-cell informatics. It enables efficient organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, streamlining data interpretation. The platform also provides dynamic filtering and a set of visualization tools, enabling researchers across various fields to easily analyze and visualize complex datasets.
In April 2023, Excelra, an India-based informatics company, acquired BISC Global for an undisclosed amount. This acquisition creates a global leader in consulting-driven bioinformatics by combining expertise in artificial intelligence, machine learning, and omics, as well as next-generation sequencing data analysis. The merger aims to accelerate bioinformatics innovation and deliver enhanced benefits to customers from both organizations. BISC Global is a Germany-based provider of bioinformatics platforms.
Major companies operating in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Partek Incorporated, Qiagen N.V.,Genedata AG,DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., Golden Helix Inc., Benchling Inc., Velsera Inc., Seqera Labs, Lifebit Biotech Ltd., Genestack Ltd., Biomatters Ltd., Schrödinger Inc., Chemical Computing Group Inc.
North America was the largest region in the bioinformatics platform market in 2025. The regions covered in the bioinformatics platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioinformatics platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the bioinformatics platform market indirectly through higher costs of high performance computing systems and storage infrastructure. Research institutions and biotech firms in regions dependent on imported hardware have experienced increased operational costs. These impacts are more visible in large scale genomic research initiatives. Tariff related budget constraints have influenced infrastructure scaling decisions. At the same time, tariffs have accelerated adoption of cloud based bioinformatics platforms that minimize upfront hardware investments.
The bioinformatics platform market research report is one of a series of new reports that provides bioinformatics platform market statistics, including bioinformatics platform industry global market size, regional shares, competitors with a bioinformatics platform market share, detailed bioinformatics platform market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics platform industry. This bioinformatics platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A bioinformatics platform is a comprehensive software system that combines various tools, algorithms, and databases to support the analysis, interpretation, and management of biological data. These platforms often enable collaborative research by integrating multidisciplinary knowledge and resources to advance progress in healthcare, drug development, and personalized medicine.
Key bioinformatics platforms include sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and more. A sequence analysis platform is a software or toolset designed to process, analyze, and interpret biological sequences, such as DNA, RNA, or protein data. It is used in genomics, proteomics, drug discovery, personalized medicine, and other fields by a range of end-users, including pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, and others.
The bioinformatics platform market consists of revenues earned by entities by providing services such as transcriptomics services, data integration and visualization, custom pipeline development, and training and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics platform market also includes sales of biological databases, cloud computing platforms, genome annotation tools, and clinical interpretation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Bioinformatics Platform Market Characteristics
3. Bioinformatics Platform Market Supply Chain Analysis
4. Global Bioinformatics Platform Market Trends and Strategies
5. Bioinformatics Platform Market Analysis of End Use Industries
7. Global Bioinformatics Platform Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Bioinformatics Platform Total Addressable Market (TAM) Analysis for the Market
9. Bioinformatics Platform Market Segmentation
10. Bioinformatics Platform Market, Industry Metrics by Country
11. Bioinformatics Platform Market Regional and Country Analysis
12. Asia-Pacific Bioinformatics Platform Market
13. China Bioinformatics Platform Market
14. India Bioinformatics Platform Market
15. Japan Bioinformatics Platform Market
16. Australia Bioinformatics Platform Market
17. Indonesia Bioinformatics Platform Market
18. South Korea Bioinformatics Platform Market
19. Taiwan Bioinformatics Platform Market
20. South East Asia Bioinformatics Platform Market
21. Western Europe Bioinformatics Platform Market
22. UK Bioinformatics Platform Market
23. Germany Bioinformatics Platform Market
24. France Bioinformatics Platform Market
25. Italy Bioinformatics Platform Market
26. Spain Bioinformatics Platform Market
27. Eastern Europe Bioinformatics Platform Market
28. Russia Bioinformatics Platform Market
29. North America Bioinformatics Platform Market
30. USA Bioinformatics Platform Market
31. Canada Bioinformatics Platform Market
32. South America Bioinformatics Platform Market
33. Brazil Bioinformatics Platform Market
34. Middle East Bioinformatics Platform Market
35. Africa Bioinformatics Platform Market
37. Bioinformatics Platform Market Competitive Landscape and Company Profiles
38. Bioinformatics Platform Market Other Major and Innovative Companies
41. Bioinformatics Platform Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Bioinformatics Platform Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses bioinformatics platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bioinformatics platform? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioinformatics platform market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Platform Type: Sequence Analysis Platforms; Sequence Alignment Platforms; Sequence Manipulation Platforms; Structural And Functional Analysis Platforms; Other Platforms2) By Application: Genomics; Proteomics; Drug Discovery; Personalized Medicine; Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Healthcare Providers; Other End Users
Subsegments:
1) By Sequence Analysis Platforms: Whole Genome Sequencing (WGS) Platforms; Targeted Sequencing Platforms; RNA Sequencing Platforms; Metagenomic Sequencing Platforms; Exome Sequencing Platforms2) By Sequence Alignment Platforms: Global Alignment Tools; Local Alignment Tools; Pairwise Alignment Tools; Multiple Sequence Alignment Tools; Structural Alignment Tools
3) By Sequence Manipulation Platforms: Sequence Assembly Tools; Sequence Editing Tools; Sequence Visualization Tools; Sequence Conversion Tools
4) By Structural And Functional Analysis Platforms: Protein Structure Prediction Tools; Structural Bioinformatics Tools; Functional Annotation Tools; Molecular Docking Platforms; Pathway Analysis Tools
5) By Other Platforms: Data Integration Platforms; Data Visualization Platforms; Bioinformatics Workflow Management Platforms; Cloud-Based Bioinformatics Platforms
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Dassault Systèmes SE; Agilent Technologies Inc.; Illumina Inc.; Wuxi NextCODE; PerkinElmer Inc.; Partek Incorporated; Qiagen N.V.;Genedata AG;DNAnexus Inc.; Sophia Genetics S.A.; Accelrys Inc.; DNASTAR Inc.; Gene Codes Corporation; BGI Group; Fios Genomics Ltd.; Golden Helix Inc.; Benchling Inc.; Velsera Inc.; Seqera Labs; Lifebit Biotech Ltd.; Genestack Ltd.; Biomatters Ltd.; Schrödinger Inc.; Chemical Computing Group Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Bioinformatics Platform market report include:- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Dassault Systèmes SE
- Agilent Technologies Inc.
- Illumina Inc.
- Wuxi NextCODE
- PerkinElmer Inc.
- Partek Incorporated
- Qiagen N.V.
- Genedata AG
- DNAnexus Inc.
- Sophia Genetics S.A.
- Accelrys Inc.
- DNASTAR Inc.
- Gene Codes Corporation
- BGI Group
- Fios Genomics Ltd.
- Golden Helix Inc.
- Benchling Inc.
- Velsera Inc.
- Seqera Labs
- Lifebit Biotech Ltd.
- Genestack Ltd.
- Biomatters Ltd.
- Schrödinger Inc.
- Chemical Computing Group Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.27 Billion |
| Forecasted Market Value ( USD | $ 15.19 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
